ArticleEuropean journal of cancer (Oxford, England : 1990)2022

Antibody titres before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients with cancer.

Yana Debie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.